{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:48:38Z","timestamp":1792795718709,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2021R1A2C2004224"],"award-info":[{"award-number":["NRF-2021R1A2C2004224"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Backgrounds<\/jats:title>\n                <jats:p>Rheumatoid arthritis (RA) is a chronic and systemic autoimmune disease characterized by synovial inflammation-mediated progressive destruction of the cartilage and bone, resulting in reduced quality of life. We primed human telomerase reverse transcriptase-overexpressing immortalized human adipose tissue-derived mesenchymal stem cells (iMSCs) with serum derived from a non-human primate RA model and studied the immunomodulatory ability of exosomes obtained from primed iMSCs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>After immunophenotyping, nanoparticle tracking analysis, and in vitro functional tests, Dulbecco\u2019s phosphate-buffered saline (dPBS, Group C), exosomes derived from the supernatant of iMSCs (Exo-FBS, Group E), exosomes derived from the supernatant of iMSCs primed with RA serum (Exo-RA, Group F), and methotrexate (Group M) were administered in collagen-induced arthritis (CIA) model mice. dPBS was administered to the normal (N) group for comparison (n\u2009=\u200910\/group).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Exo-RA had a significantly higher number of exosomes compared to Exo-FBS when measured with nanoparticle tracking analysis or exosome marker CD81, and Transforming growth factor-\u03b21 amounts were significantly higher in Exo-RA than in Exo-FBS. When Exo-FBS or Exo-RA was administered to the collagen-induced arthritis model, serum interleukin (IL)-4 and the proportion of Th2 (CD4+CD25+GATA3+) and M2 (CD11c\u2009\u2212\u2009CD206+ of CD45+CD64+) cells were significantly increased compared to the control group. Furthermore, Exo-RA could alleviate cartilage damage by significantly lowering the concentrations of proinflammatory cytokines such as tumor necrosis factor-\u03b1, keratinocyte chemoattractant, and IL-12p70.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Exosomes derived from disease-condition-serum-primed iMSCs ameliorated cartilage damage in a RA model by enhancing TGF-\u03b21 production, inducing Th2 and M2 polarization and lowering proinflammatory cytokines, TNF-\u03b1, KC, and IL-12p70 in the host. Patient-derived serum can be used as an iMSC priming strategy in iMSC-derived exosome treatment of RA.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-023-03523-0","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T20:17:06Z","timestamp":1696450626000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Exosomes derived from mesenchymal stem cells primed with disease-condition-serum improved therapeutic efficacy in a mouse rheumatoid arthritis model via enhanced TGF-\u03b21 production"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7213-695X","authenticated-orcid":false,"given":"Eun Wha","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.-Rang","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwoo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bongkum","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungjoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,4]]},"reference":[{"key":"3523_CR1","doi-asserted-by":"publisher","first-page":"105687","DOI":"10.1016\/j.intimp.2019.105687","volume":"74","author":"D Ma","year":"2019","unstructured":"Ma D, Xu K, Zhang G, Liu Y, Gao J, Tian M, Wei C, Li J, Zhang L. Immunomodulatory effect of human umbilical cord mesenchymal stem cells on T lymphocytes in rheumatoid arthritis. Int Immunopharmacol. 2019;74:105687.","journal-title":"Int Immunopharmacol"},{"key":"3523_CR2","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s10787-018-0459-z","volume":"26","author":"MB Yu","year":"2018","unstructured":"Yu MB, Firek A, William HR, Langridge WHR. Predicting methotrexate resistance in rheumatoid arthritis patients. Inflammopharmacology. 2018;26:699\u2013708.","journal-title":"Inflammopharmacology"},{"key":"3523_CR3","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ejmech.2018.09.027","volume":"158","author":"W Wang","year":"2018","unstructured":"Wang W, Zhou H, Liu L. Side effects of methotrexate therapy for rheumatoid arthritis: a systematic review. Eur J Med Chem. 2018;158:502\u201316.","journal-title":"Eur J Med Chem"},{"key":"3523_CR4","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1136\/ard.2006.065615","volume":"66","author":"GM Bartelds","year":"2007","unstructured":"Bartelds GM, Wijbrandts CA, Nurmohamed MT, Stapel S, Lems WF, Aarden L, Dijkmans BAC, Tak PP, Gerrit Jan Wolbink GJ. Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis. Ann Rheum Dis. 2007;66:921\u20136.","journal-title":"Ann Rheum Dis"},{"key":"3523_CR5","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1159\/000289205","volume":"11","author":"PP Sfikakis","year":"2010","unstructured":"Sfikakis PP. The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions. Curr Dir Autoimmun. 2010;11:180\u2013210.","journal-title":"Curr Dir Autoimmun"},{"key":"3523_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s13287-022-02985-y","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, Gao J, Liang Z, Gao C, Niu Q, Wu F, Zhang L. Mesenchymal stem cells and their microenvironment. Stem Cell Res Ther. 2022;13:429.","journal-title":"Stem Cell Res Ther"},{"key":"3523_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4067\/S0716-97602012000300008","volume":"45","author":"FE Figueroa","year":"2012","unstructured":"Figueroa FE, Carri\u00f3n F, Villanueva S, Khoury M. Mesenchymal stem cell treatment for autoimmune diseases: a critical review. Biol Res. 2012;45:269\u201377.","journal-title":"Biol Res"},{"key":"3523_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13287-022-02782-7","volume":"13","author":"SA Jasim","year":"2022","unstructured":"Jasim SA, Yumashev AV, Abdelbasset WK, Margiana R, Markov A, Suksatan W, Pineda B, Thangavelu L, Ahmadi SH. Shining the light on clinical application of mesenchymal stem cell therapy in autoimmune diseases. Stem Cell Res Ther. 2022;13:101.","journal-title":"Stem Cell Res Ther"},{"key":"3523_CR9","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12967-014-0260-8","volume":"12","author":"M Madrigal","year":"2014","unstructured":"Madrigal M, Rao KS, Riordan NH. A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods. J Transl Med. 2014;12:260.","journal-title":"J Transl Med"},{"key":"3523_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13287-020-01659-x","volume":"11","author":"A\u00c9 Silva-Carvalho","year":"2020","unstructured":"Silva-Carvalho A\u00c9, Rodrigues LP, Schiavinato JL, Alborghetti MR, Bettarello G, Sim\u00f5es BP, Neves FAR, Panepucci RA, de Carvalho JL, Saldanha-Araujo F. GVHD-derived plasma as a priming strategy of mesenchymal stem cells. Stem Cell Res Ther. 2020;11:156.","journal-title":"Stem Cell Res Ther"},{"key":"3523_CR11","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/S0140-6736(04)15695-X","volume":"363","author":"PR Vulliet","year":"2004","unstructured":"Vulliet PR, Greeley M, Halloran SM, MacDonald KA, Kittleson MD. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet. 2004;363:783\u20134.","journal-title":"Lancet"},{"key":"3523_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1423-0127-18-87","volume":"18","author":"M Gong","year":"2011","unstructured":"Gong M, Bi Y, Jiang W, Zhang Y, Chen L, Hou N, Liu Y, Wei X, Chen J, Li T. Immortalized mesenchymal stem cells: an alternative to primary mesenchymal stem cells in neuronal differentiation and neuroregeneration associated studies. J Biomed Sci. 2011;18:87.","journal-title":"J Biomed Sci"},{"key":"3523_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1423-0127-17-64","volume":"17","author":"CC Tsai","year":"2010","unstructured":"Tsai CC, Chen CL, Liu HC, Lee YT, Wang HW, Hou LT, Hung SC. Overexpression of hTERT increases stem-like properties and decreases spontaneous differentiation in human mesenchymal stem cell lines. J Biomed Sci. 2010;17:64.","journal-title":"J Biomed Sci"},{"key":"3523_CR14","doi-asserted-by":"publisher","first-page":"119942","DOI":"10.1016\/j.biomaterials.2020.119942","volume":"243","author":"HY Kim","year":"2020","unstructured":"Kim HY, Kim TJ, Kang L, Kim YJ, Kang MK, Kim J, Ryu JH, Hyeon T, Yoon BW, Ko SB, Kim BS. Mesenchymal stem cell-derived magnetic extracellular nanovesicles for targeting and treatment of ischemic stroke. Biomaterials. 2020;243:119942.","journal-title":"Biomaterials"},{"key":"3523_CR15","doi-asserted-by":"publisher","first-page":"8249","DOI":"10.1002\/jcp.27669","volume":"234","author":"S Mardpour","year":"2019","unstructured":"Mardpour S, Hamidieh AA, Taleahmad S, Sharifzad F, Taghikhani A, Baharvand H. Interaction between mesenchymal stromal cell-derived extracellular vesicles and immune cells by distinct protein content. J Cell Physiol. 2019;234:8249\u201358.","journal-title":"J Cell Physiol"},{"key":"3523_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jcyt.2017.11.002","volume":"20","author":"P Wu","year":"2018","unstructured":"Wu P, Zhang B, Shi H, Qian H, Xu W. MSC-exosome: a novel cell-free therapy for cutaneous regeneration. Cytotherapy. 2018;20:291\u2013301.","journal-title":"Cytotherapy"},{"key":"3523_CR17","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nbt.2816","volume":"32","author":"JA Ankrum","year":"2014","unstructured":"Ankrum JA, Ong JF, Karp JM. Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol. 2014;32:252\u201360.","journal-title":"Nat Biotechnol"},{"key":"3523_CR18","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.3390\/ijms15034142","volume":"15","author":"Y Bo","year":"2014","unstructured":"Bo Y, Xiaomin Z, Xiaorong L. Exosomes derived from mesenchymal stem. Int J Mol Sci. 2014;15:4142\u201357.","journal-title":"Int J Mol Sci"},{"key":"3523_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1006\/dbio.2000.9912","volume":"227","author":"M Amit","year":"2000","unstructured":"Amit M, Carpenter MK, Inokuma MS, Chiu CP, Harris CP, Waknitz MA, Itskovitz-Eldor J, Thomson JA. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol. 2000;227:271\u20138.","journal-title":"Dev Biol"},{"key":"3523_CR20","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1634\/stemcells.22-5-675","volume":"22","author":"MA Baxter","year":"2004","unstructured":"Baxter MA, Wynn RF, Jowitt SN, Wraith JE, Fairbairn LJ, Bellantuono I. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells. 2004;22:675\u201382.","journal-title":"Stem Cells"},{"key":"3523_CR21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1126\/science.279.5349.349","volume":"279","author":"AG Bodnar","year":"1998","unstructured":"Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279:349\u201352.","journal-title":"Science"},{"key":"3523_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3727\/096368915X688470","volume":"25","author":"EW Choi","year":"2016","unstructured":"Choi EW, Shin IS, Song JW, Lee M, Yun TW, Yang J, Choi KS, Kim SJ. Effects of transplantation of CTLA4Ig-overexpressing adipose tissue-derived mesenchymal stem cells in mice with sustained severe rheumatoid arthritis. Cell Transplant. 2016;25:243\u201359.","journal-title":"Cell Transplant"},{"key":"3523_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jcyt.2014.10.010","volume":"17","author":"EW Choi","year":"2015","unstructured":"Choi EW, Yun TW, Song JW, Lee M, Yang J, Choi KS. Preventive effects of CTLA4Ig-overexpressing adipose tissue-derived mesenchymal stromal cells in rheumatoid arthritis. Cytotherapy. 2015;17:271\u201382.","journal-title":"Cytotherapy"},{"key":"3523_CR24","doi-asserted-by":"publisher","first-page":"17297","DOI":"10.1038\/s41598-018-35602-1","volume":"8","author":"EW Choi","year":"2018","unstructured":"Choi EW, Song JW, Ha N, Choi YI, Kim S. CKD-506, a novel HDAC6-selective inhibitor, improves renal outcomes and survival in a mouse model of systemic lupus erythematosus. Sci Rep. 2018;8:17297.","journal-title":"Sci Rep"},{"key":"3523_CR25","doi-asserted-by":"publisher","first-page":"18532","DOI":"10.1038\/s41598-022-21381-3","volume":"12","author":"EW Choi","year":"2022","unstructured":"Choi EW, Kim HJ, Jung YC, Go HS, Seong JK. Effects of high fat diet-induced obesity on pathophysiology, immune cells, and therapeutic efficacy in systemic lupus erythematosus. Sci Rep. 2022;12:18532.","journal-title":"Sci Rep"},{"key":"3523_CR26","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/s41598-018-20566-z","volume":"8","author":"EW Choi","year":"2018","unstructured":"Choi EW, Lee KW, Park H, Kim H, Lee JH, Song JW, Yang J, Kwon Y, Kim TM, Park JB, Kim S. Therapeutic effects of anti-CD154 antibody in cynomolgus monkeys with advanced rheumatoid arthritis. Sci Rep. 2018;8:2135.","journal-title":"Sci Rep"},{"key":"3523_CR27","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3389\/fimmu.2017.01958","volume":"8","author":"S Fukui","year":"2018","unstructured":"Fukui S, Iwamoto N, Takatani A, Igawa T, Shimizu T, Umeda M, Nishino A, Horai Y, Hirai Y, Koga T, Kawashiri SY, Tamai M, Ichinose K, Nakamura H, Origuchi T, Masuyama R, Kosai K, Yanagihara K, Kawakami A. M1 and M2 monocytes in rheumatoid arthritis: a contribution of imbalance of M1\/M2 monocytes to osteoclastogenesis. Front Immunol. 2018;8:1958.","journal-title":"Front Immunol"},{"key":"3523_CR28","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s00018-019-03235-w","volume":"77","author":"K Van Raemdonck","year":"2020","unstructured":"Van Raemdonck K, Umar S, Palasiewicz K, Volkov S, Volin MV, Arami S, Chang HJ, Zanotti B, Sweiss N, Shahrara S. CCL21\/CCR7 signaling in macrophages promotes joint inflammation and Th17-mediated osteoclast formation in rheumatoid arthritis. Cell Mol Life Sci. 2020;77:1387\u201399.","journal-title":"Cell Mol Life Sci"},{"key":"3523_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41584-018-0109-2","volume":"15","author":"Z Chen","year":"2019","unstructured":"Chen Z, Bozec A, Ramming A, Schett G. Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis. Nat Rev Rheumatol. 2019;15:9\u201317.","journal-title":"Nat Rev Rheumatol"},{"key":"3523_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3727\/215517916X693159","volume":"9","author":"Y Yoshizumi","year":"2016","unstructured":"Yoshizumi Y, Yukawa H, Iwaki R, Fujinaka S, Kanou A, Kanou Y, Yamada T, Nakagawa S, Ohara T, Nakagiri K, Ogihara Y, Tsutsui Y, Hayashi Y, Ishigami M, Baba Y, Ishikawa T. Immunomodulatory effects of adipose tissue-derived stem cells on concanavalin A-induced acute liver injury in mice. Cell Med. 2016;9:21\u201333.","journal-title":"Cell Med"},{"key":"3523_CR31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13287-019-1156-6","volume":"10","author":"L Salda\u00f1a","year":"2019","unstructured":"Salda\u00f1a L, Bensiamar F, Vall\u00e9s G, Mancebo FJ, Garc\u00eda-Rey E, Vilaboa N. Immunoregulatory potential of mesenchymal stem cells following activation by macrophage-derived soluble factors. Stem Cell Res Ther. 2019;10:58.","journal-title":"Stem Cell Res Ther"},{"key":"3523_CR32","doi-asserted-by":"publisher","first-page":"1759720X2211002","DOI":"10.1177\/1759720X221100294","volume":"14","author":"YJ Li","year":"2022","unstructured":"Li YJ, Chen Z. Cell-based therapies for rheumatoid arthritis: opportunities and challenges. Ther Adv Musculoskelet Dis. 2022;14:1759720X221100294.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"3523_CR33","doi-asserted-by":"publisher","first-page":"714832","DOI":"10.3389\/fimmu.2021.714832","volume":"12","author":"C Yang","year":"2021","unstructured":"Yang C, Sun J, Tian Y, Li H, Zhang L, Yang J, Wang J, Zhang J, Yan S, Xu D. Immunomodulatory effect of MSCs and MSCs-derived extracellular vesicles in systemic lupus erythematosus. Front Immunol. 2021;12:714832.","journal-title":"Front Immunol"},{"key":"3523_CR34","doi-asserted-by":"publisher","first-page":"24120","DOI":"10.1038\/srep24120","volume":"6","author":"M Di Trapani","year":"2016","unstructured":"Di Trapani M, Bassi G, Midolo M, Gatti A, Kamga PT, Cassaro A, Carusone R, Adamo A, Krampera M. Differential and transferable modulatory effects of mesenchymal stromal cell-derived extracellular vesicles on T, B and NK cell functions. Sci Rep. 2016;6:24120.","journal-title":"Sci Rep"},{"key":"3523_CR35","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s13075-016-1158-z","volume":"18","author":"Y Wang","year":"2016","unstructured":"Wang Y, Liang J, Qin H, Ge Y, Du J, Lin J, Zhu X, Wang J, Xu J. Elevated expression of miR-142-3p is related to the pro-inflammatory function of monocyte-derived dendritic cells in SLE. Arthritis Res Ther. 2016;18:263.","journal-title":"Arthritis Res Ther"},{"key":"3523_CR36","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1177\/1545968320926164","volume":"34","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhang Y, Chopp M, Zhang ZG, Mahmood A, Xiong Y. Mesenchymal stem cell-derived exosomes improve functional recovery in rats after traumatic brain injury: a dose-response and therapeutic window study. Neurorehabil Neural Repair. 2020;34:616\u201326.","journal-title":"Neurorehabil Neural Repair"},{"key":"3523_CR37","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1084\/jem.20082293","volume":"206","author":"K Boniface","year":"2009","unstructured":"Boniface K, Bak-Jensen KS, Li Y, Blumenschein WM, McGeachy MJ, McClanahan TK, McKenzie BS, Kastelein RA, Cua DJ, de Waal MR. Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2\/EP4 receptor signaling. J Exp Med. 2009;206:535\u201348.","journal-title":"J Exp Med"},{"key":"3523_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13317-020-00135-z","volume":"11","author":"LN Samimi","year":"2020","unstructured":"Samimi LN, Farhadi E, Tahmasebi MN, Jamshidi A, Vaziri AS, Mahmoudi M. NF-\u03baB signaling in rheumatoid arthritis with focus on fibroblast-like synoviocytes. Autoimmun Highlights. 2020;11:11.","journal-title":"Autoimmun Highlights"},{"key":"3523_CR39","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1101\/gad.14.2.187","volume":"14","author":"M Bitzer","year":"2000","unstructured":"Bitzer M, von Gersdorff G, Liang D, Dominguez-Rosales A, Beg AA, Rojkind M, B\u00f6ttinger EP. A mechanism of suppression of TGF\u2013\u03b2\/SMAD signaling by NF-\u03baB\/RelA. Genes Dev. 2000;14:187\u201397.","journal-title":"Genes Dev"},{"key":"3523_CR40","doi-asserted-by":"publisher","first-page":"84","DOI":"10.18053\/jctres.02.201603.005","volume":"2","author":"M Farrugia","year":"2016","unstructured":"Farrugia M, Baron B. The role of TNF-\u03b1 in rheumatoid arthritis: a focus on regulatory T cells. J Clin Transl Res. 2016;2:84\u201390.","journal-title":"J Clin Transl Res"},{"key":"3523_CR41","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/j.1476-5381.2009.00367.x","volume":"158","author":"SM Vieira","year":"2009","unstructured":"Vieira SM, Lemos HP, Grespan R, Napimoga MH, Dal-Secco D, Freitas A, Cunha TM, Verri WA Jr, Souza-Junior DA, Jamur MC, Fernandes KS, Oliver C, Silva JS, Teixeira MM, Cunha FQ. A crucial role for TNF-\u03b1 in mediating neutrophil influx induced by endogenously generated or exogenous chemokines, KC\/CXCL1 and LIX\/CXCL5. Br J Pharmacol. 2009;158:779\u201389.","journal-title":"Br J Pharmacol"},{"key":"3523_CR42","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s10067-005-0106-0","volume":"25","author":"L Petrovic-Rackov","year":"2006","unstructured":"Petrovic-Rackov L, Pejnovic N. Clinical significance of IL-18, IL-15, IL-12 and TNF-\u03b1 measurement in rheumatoid arthritis. Clin Rheumatol. 2006;25:448\u201352.","journal-title":"Clin Rheumatol"},{"key":"3523_CR43","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1046\/j.1365-2249.2000.01095.x","volume":"119","author":"WU Kim","year":"2000","unstructured":"Kim WU, Min SY, Cho ML, Youn J, Min JK, Lee SH, Park SH, Cho CS, Kim HY. The role of IL-12 in inflammatory activity of patients with rheumatoid arthritis (RA). Clin Exp Immunol. 2000;119:175\u201381.","journal-title":"Clin Exp Immunol"},{"key":"3523_CR44","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/1529-0131(199802)41:2<306::AID-ART15>3.0.CO;2-4","volume":"41","author":"Y Morita","year":"1998","unstructured":"Morita Y, Yamamura M, Nishida K, Harada S, Okamoto H, Inoue H, Ohmoto Y, Modlin RL, Makino H. Expression of interleukin-12 in synovial tissue from patients with rheumatoid arthritis. Arthritis Rheum. 1998;41:306\u201314.","journal-title":"Arthritis Rheum"},{"key":"3523_CR45","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3389\/fimmu.2019.00446","volume":"10","author":"A Adamo","year":"2019","unstructured":"Adamo A, Brandi J, Caligola S, Delfino P, Bazzoni R, Carusone R, Cecconi D, Giugno R, Manfredi M, Robotti E, Marengo E, Bassi G, Kamga PT, Collo GD, Gatti A, Mercuri A, Arigoni M, Olivero M, Calogero RA, Krampera M. Extracellular vesicles mediate mesenchymal stromal cell-dependent regulation of B Cell PI3K-AKT signaling pathway and actin cytoskeleton. Front Immunol. 2019;10:446.","journal-title":"Front Immunol"},{"key":"3523_CR46","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.actbio.2020.06.037","volume":"113","author":"D Xin","year":"2020","unstructured":"Xin D, Li T, Chu X, Ke H, Yu Z, Cao L, Bai X, Liu D, Wang Z. Mesenchymal stromal cell-derived extracellular vesicles modulate microglia\/macrophage polarization and protect the brain against hypoxia-ischemic injury in neonatal mice by targeting delivery of miR-21a-5p. Acta Biomater. 2020;113:597\u2013613.","journal-title":"Acta Biomater"},{"key":"3523_CR47","doi-asserted-by":"publisher","first-page":"105985","DOI":"10.1016\/j.intimp.2019.105985","volume":"78","author":"J Zheng","year":"2020","unstructured":"Zheng J, Zhu L, In II, Chen Y, Jia N, Zhu W. Bone marrow-derived mesenchymal stem cells-secreted exosomal microRNA-192-5p delays inflammatory response in rheumatoid arthritis. Int Immunopharmacol. 2020;78:105985.","journal-title":"Int Immunopharmacol"},{"key":"3523_CR48","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.4049\/jimmunol.1800304","volume":"201","author":"Z Chen","year":"2018","unstructured":"Chen Z, Wang H, Xia Y, Yan F, Lu Y. Therapeutic potential of mesenchymal cell-derived miRNA-150-5p-expressing exosomes in rheumatoid arthritis mediated by the modulation of MMP14 and VEGF. J Immunol. 2018;201:2472\u201382.","journal-title":"J Immunol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-023-03523-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-023-03523-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-023-03523-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T05:35:53Z","timestamp":1700372153000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-023-03523-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,4]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3523"],"URL":"https:\/\/doi.org\/10.1186\/s13287-023-03523-0","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,4]]},"assertion":[{"value":"19 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was reviewed and approved by the IACUC of Kangwon National University (KW-210824-1) and the IACUC of GenNBio (GN-IACUC-22-01-10) as follows; for in vitro functional test: (1) Title of the approved project: The effects of advanced mesenchymal stem cell-derived materials on rheumatoid arthritis (2) Name of the institutional approval committee: IACUC of Kangwon National University (3) Approval number: KW-210824-1 (4) Date of approval: August 30, 2021\/for in vivo study: (1) Title of the approved project: The therapeutic effect of advanced exosome in mouse rheumatoid arthritis model (2) Name of the institutional approval committee: IACUC of GenNBio (3) Approval number: GN-IACUC-22-01-10 (4) Date of approval: January 14, 2022.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JS, BC, and SK are employees of GenNBio Inc. The remaining authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"283"}}